Introduction
Immune challenge induces marked behavioral changes, including a reduction in drinking or eating (anorexia), fatigue, reduction in pleasure seeking behavior (anhedonia), or reduction in exploratory behavior (Andreasson et al. 2007 ; see reviews Dantzer, 2001; De la Garza, 2005) . The neurological substrates by which illness induces behavioral symptoms are not well-established. However, neurovegative symptoms, including inhibition of ingestive behavior, likely involve brain regions that are associated with homeostasis and motivation. Suppressed food intake, in particular, is associated with poorer outcomes of chronic illness (Hauser et al. 2006; Strassburg and Anker 2006) . Consequently, increased understanding of the neurobiological substrates impacted by immune challenges and inflammation could lead to clinically important strategies for intervention.
Ingestive behavior is ultimately the result of interplay between peripheral signals related to physiological states, and cognitive and affective drive related to learning, arousal and hedonics (Berthoud, 2004) . Circulating signals (e.g. leptin, ghrelin) interacting with brain regions including the arcuate hypothalamus and/or neural pathways originating in the caudal brainstem (e.g. dorsal vagal complex, ventrolateral medulla) contribute to "bottom-up" drive on hypothalamic neural circuits (reviewed in Berthoud, 2004; Elmquist et al. 2005; Jobst et al., 2004 ) that mediate the induction of eating behavior (orexigenic) or inhibition of eating behavior (anorexigenic). Within the arcuate nucleus, two distinct populations of neurons have been identified that exert opposite effects on feeding behavior. Activity in arcuate neurons that express the neuropeptides pro-opiomelanocortin (POMC) and cocaine and amphetamine regulated transcript (CART) is associated with inhibition of eating, whereas a separate population of neuropeptide Y containing neurons seem to act to enhance feeding. In contrast, "top-down" influence derives from forebrain regions including the medial prefrontal cortex, amygdala, and the nucleus accumbens (Maldonado-Irizarry et al., 1995; Kelley and Swanson, 1997; Petrovich and Gallagher, 2003; Stratford and Kelley, 1997, 1999; Reynolds and Berridge, 2002; Will et al., 2004; Baldo et al., 2005; Zheng et al., 2003) 
a r t i c l e i n f o a b s t r a c t
Immune challenge induces behavioral changes including reduced ingestion of palatable food. Multiple pathways likely contribute to this effect, including viscerosensory pathways controlling hypothalamic feeding circuits or by influence on "reward" circuitry previously established to control ingestive behavior.
To investigate whether the effects of immune challenge may influence this network, we compared brain activation patterns in animals trained to drink a palatable sweetened milk solution and treated systemically with either the immune stimulant lipopolysaccharide (LPS) or saline. Brain sections were processed for localization of the activation marker c-Fos in neurons of regions implicated in regulation of feeding behavior. Sweetened milk ingestion was associated with increased numbers of c-Fos positive neurons in the caudal core and shell of the nucleus accumbens (NAc), the paraventricular thalamus (PVT), central nucleus of the amygdala (CEA), the basal lateral amygdala (BLA), in orexin-A containing neurons of the lateral hypothalamus (LH), and in cocaine and amphetamine regulated transcript (CART) neurons of the arcuate hypothalamus. In LPS-treated animals sweetened milk consumption was significantly reduced, as was c-Fos induction in the hypothalamic orexin-A and CART neurons, and in the BLA. In addition, induction of c-Fos in the rostral regions of the NAc, the PVT, and CEA was increased following LPS treatment, compared to controls. The findings from this study point to a network of brain regions (LH, PVT, NAc, and BLA) previously implicated in the modulation of feeding behavior, reward, and arousal that may also contribute to neural substrates involved in the reorganization of behavioral priorities that occurs during sickness. © 2008 Elsevier Inc. All rights reserved. 
